rediff.com Home > Money > Budget 2001 > D&B Budget Impact Analysis Banner Ads
Channels: Astrology | Broadband | Contests | E-cards | Money | Movies | Romance | Search | Weather | Wedding | Women
Partner Channels: Auctions | Auto | Bill Pay | Jobs | Lifestyle | Technology | Travel
March 2, 2001                                       Feedback  

    - COLUMNISTS
    - INTERVIEWS
    - CREDIT POLICY
    - ECONOMIC SURVEY
    - GOVT & ECONOMY
    - BUDGET RUN-UP
    - RAILWAY BUDGET
    - EXIM POLICY '00
    - BUDGET SPEECH '00


    
      


    - BUDGET PROCESS

    - BUDGET 00-01
    - BUDGET 99-00
    - BUDGET 98-99
    - BUDGET 97-98

    - NEWSLINKS


Information you can use

   The Best Budget Sites
   Ministry of Finance
   Budget 2000
   Reserve Bank of India


 




Banner Ads
Banner Ads
Banner Ads
Banner Ads
 Search the Internet
         Tips
 Sites: Finance, Investment
E-Mail this report to a friend
Print this page

Budget Impact on Pharmaceuticals sector

Overall impact: Positive

Excise Duty

  • No change in excise duty

Customs Duty

  • Full exemption from all customs duties on Enoxaparin (both bulk drugs and formulations) withdrawn and a concessional rate of 15% BCD + 16% CVD + 4% SAD imposed.

Other Changes

  • Span of price control has been reduced substantially. However, the Government has retained power to intervene comprehensively in cases where prices behave abnormally.

  • Weighted deduction of 150% of the expenditure on in-house research and development in certain areas allowed to companies has been extended to biotechnology as well for clinical trials, filing patents and obtaining regulatory approvals.

  • The tax payable on the distribution of dividends of domestic companies reduced to 10% from the current 20%. This is a positive feature for Pharma companies who have a track record of paying high dividends

Rediff-Dun & Bradstreet Budget Impact Analysis
Budget 2001

Tell us what you think of this analysis